Cargando…

Solenopsin A and analogs exhibit ceramide-like biological activity

BACKGROUND: (−)-Solenopsin A is a piperidine alkaloid that is a component of the venom of the fire ant Solenopsis invicta. Previously, we have demonstrated that solenopsin exhibit anti-angiogenic activity and downregulate phosphoinositol-3 kinase (PI3K) in the p53 deficient renal cell carcinoma cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlsson, Isabella, Zhou, Xin, Thomas, Raquela, Smith, Allorie T, Bonner, Michael Y, Bakshi, Pooja, Banga, Ajay K, Bowen, J Phillip, Qabaja, Ghassan, Ford, Shavon L, Ballard, Matthew D, Petersen, Kimberly S, Li, Xuechen, Chen, Guangping, Ogretmen, Besim, Zhang, Jin, Watkins, E Blake, Arnold, Rebecca S, Arbiser, Jack L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443652/
https://www.ncbi.nlm.nih.gov/pubmed/26015865
http://dx.doi.org/10.1186/s13221-015-0030-2
_version_ 1782373031464665088
author Karlsson, Isabella
Zhou, Xin
Thomas, Raquela
Smith, Allorie T
Bonner, Michael Y
Bakshi, Pooja
Banga, Ajay K
Bowen, J Phillip
Qabaja, Ghassan
Ford, Shavon L
Ballard, Matthew D
Petersen, Kimberly S
Li, Xuechen
Chen, Guangping
Ogretmen, Besim
Zhang, Jin
Watkins, E Blake
Arnold, Rebecca S
Arbiser, Jack L
author_facet Karlsson, Isabella
Zhou, Xin
Thomas, Raquela
Smith, Allorie T
Bonner, Michael Y
Bakshi, Pooja
Banga, Ajay K
Bowen, J Phillip
Qabaja, Ghassan
Ford, Shavon L
Ballard, Matthew D
Petersen, Kimberly S
Li, Xuechen
Chen, Guangping
Ogretmen, Besim
Zhang, Jin
Watkins, E Blake
Arnold, Rebecca S
Arbiser, Jack L
author_sort Karlsson, Isabella
collection PubMed
description BACKGROUND: (−)-Solenopsin A is a piperidine alkaloid that is a component of the venom of the fire ant Solenopsis invicta. Previously, we have demonstrated that solenopsin exhibit anti-angiogenic activity and downregulate phosphoinositol-3 kinase (PI3K) in the p53 deficient renal cell carcinoma cell line 786-O. Solenopsin has structural similarities to ceramide, a major endogenous regulator of cell signaling and cancer therapy induced apoptosis. METHODS: Different analogs of solenopsin were synthesized in order to explore structure-activity relationships. The anti-proliferative effect of solenopsin and analogs was tested on six different cell lines, including three tumor cell lines, two normal cutaneous cell lines, and one immortalized hyperproliferative cell line. FRET-based reporters were used to study the affect of solenopsin and analogs on Akt activity and PDK1 activation and sucrose density gradient fractionation was performed to examine recruitment of PTEN to membrane rafts. Western-blotting was used to evaluate the affect of solenopsin and analogs on the Akt and the MAPK 44/42 pathways in three different tumor cell lines. Measurement of cellular oxygen consumption rate together with autophagy staining was performed to study mitochondrial function. Finally, the affect of solenopsin and analogs on ROS production was investigated. RESULTS: In this paper we demonstrate that solenopsin analogs with potent anti-proliferative effects can be synthesized from inexpensive dimethylpyridines. To determine whether solenopsin and analogs act as ceramide analogs, we examined the effect of solenopsin and analogs on two stereotypic sites of ceramide activity, namely at lipid rafts and mitochondria. We found that native solenopsin, (−)-solenopsin A, inhibits functional Akt activity and PDK1 activation in lipid rafts in a similar fashion as ceramide. Both cis and trans analogs of solenopsin reduce mitochondrial oxygen consumption, increase reactive oxygen, and kill tumor cells with elevated levels of Akt phosphorylation. However, only solenopsin induces mitophagy, like ceramide. CONCLUSIONS: The requirements for ceramide induced mitophagy and inhibition of Akt activity and PDK1 activation in lipid rafts are under strict stereochemical control. The naturally occurring (−)-solenopsin A mimic some of the functions of ceramide and may be therapeutically useful in the treatment of hyperproliferative and malignant disorders of the skin, even in the presence of elevated levels of Akt. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13221-015-0030-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4443652
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44436522015-05-27 Solenopsin A and analogs exhibit ceramide-like biological activity Karlsson, Isabella Zhou, Xin Thomas, Raquela Smith, Allorie T Bonner, Michael Y Bakshi, Pooja Banga, Ajay K Bowen, J Phillip Qabaja, Ghassan Ford, Shavon L Ballard, Matthew D Petersen, Kimberly S Li, Xuechen Chen, Guangping Ogretmen, Besim Zhang, Jin Watkins, E Blake Arnold, Rebecca S Arbiser, Jack L Vasc Cell Research BACKGROUND: (−)-Solenopsin A is a piperidine alkaloid that is a component of the venom of the fire ant Solenopsis invicta. Previously, we have demonstrated that solenopsin exhibit anti-angiogenic activity and downregulate phosphoinositol-3 kinase (PI3K) in the p53 deficient renal cell carcinoma cell line 786-O. Solenopsin has structural similarities to ceramide, a major endogenous regulator of cell signaling and cancer therapy induced apoptosis. METHODS: Different analogs of solenopsin were synthesized in order to explore structure-activity relationships. The anti-proliferative effect of solenopsin and analogs was tested on six different cell lines, including three tumor cell lines, two normal cutaneous cell lines, and one immortalized hyperproliferative cell line. FRET-based reporters were used to study the affect of solenopsin and analogs on Akt activity and PDK1 activation and sucrose density gradient fractionation was performed to examine recruitment of PTEN to membrane rafts. Western-blotting was used to evaluate the affect of solenopsin and analogs on the Akt and the MAPK 44/42 pathways in three different tumor cell lines. Measurement of cellular oxygen consumption rate together with autophagy staining was performed to study mitochondrial function. Finally, the affect of solenopsin and analogs on ROS production was investigated. RESULTS: In this paper we demonstrate that solenopsin analogs with potent anti-proliferative effects can be synthesized from inexpensive dimethylpyridines. To determine whether solenopsin and analogs act as ceramide analogs, we examined the effect of solenopsin and analogs on two stereotypic sites of ceramide activity, namely at lipid rafts and mitochondria. We found that native solenopsin, (−)-solenopsin A, inhibits functional Akt activity and PDK1 activation in lipid rafts in a similar fashion as ceramide. Both cis and trans analogs of solenopsin reduce mitochondrial oxygen consumption, increase reactive oxygen, and kill tumor cells with elevated levels of Akt phosphorylation. However, only solenopsin induces mitophagy, like ceramide. CONCLUSIONS: The requirements for ceramide induced mitophagy and inhibition of Akt activity and PDK1 activation in lipid rafts are under strict stereochemical control. The naturally occurring (−)-solenopsin A mimic some of the functions of ceramide and may be therapeutically useful in the treatment of hyperproliferative and malignant disorders of the skin, even in the presence of elevated levels of Akt. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13221-015-0030-2) contains supplementary material, which is available to authorized users. BioMed Central 2015-05-08 /pmc/articles/PMC4443652/ /pubmed/26015865 http://dx.doi.org/10.1186/s13221-015-0030-2 Text en © Karlsson et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Karlsson, Isabella
Zhou, Xin
Thomas, Raquela
Smith, Allorie T
Bonner, Michael Y
Bakshi, Pooja
Banga, Ajay K
Bowen, J Phillip
Qabaja, Ghassan
Ford, Shavon L
Ballard, Matthew D
Petersen, Kimberly S
Li, Xuechen
Chen, Guangping
Ogretmen, Besim
Zhang, Jin
Watkins, E Blake
Arnold, Rebecca S
Arbiser, Jack L
Solenopsin A and analogs exhibit ceramide-like biological activity
title Solenopsin A and analogs exhibit ceramide-like biological activity
title_full Solenopsin A and analogs exhibit ceramide-like biological activity
title_fullStr Solenopsin A and analogs exhibit ceramide-like biological activity
title_full_unstemmed Solenopsin A and analogs exhibit ceramide-like biological activity
title_short Solenopsin A and analogs exhibit ceramide-like biological activity
title_sort solenopsin a and analogs exhibit ceramide-like biological activity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443652/
https://www.ncbi.nlm.nih.gov/pubmed/26015865
http://dx.doi.org/10.1186/s13221-015-0030-2
work_keys_str_mv AT karlssonisabella solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT zhouxin solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT thomasraquela solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT smithalloriet solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT bonnermichaely solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT bakshipooja solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT bangaajayk solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT bowenjphillip solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT qabajaghassan solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT fordshavonl solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT ballardmatthewd solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT petersenkimberlys solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT lixuechen solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT chenguangping solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT ogretmenbesim solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT zhangjin solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT watkinseblake solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT arnoldrebeccas solenopsinaandanalogsexhibitceramidelikebiologicalactivity
AT arbiserjackl solenopsinaandanalogsexhibitceramidelikebiologicalactivity